| Interactions between Xenobiotics and DME (XEOTIC)
|
| Health or Environmental Toxicant(s) |
| Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Carcinogen |
| DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME CBR3 |
[1] |
| Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Diethylhexyl phthalate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01004
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Diethylhexyl phthalate up-regulates the expression of DME CBR3 |
[2] |
| Glycidamide |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01009
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Health Hazard |
| DME Modulation |
Glycidamide up-regulates the expression of DME CBR3 |
[3] |
| Natural Product(s), Extract(s) or Medicine(s) |
| Natural Product |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
| Gedunin |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01311
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Gedunin up-regulates the expression of DME CBR3 |
[4] |
| Guggulsterone |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01579
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Natural Product |
| DME Modulation |
Guggulsterone up-regulates the expression of DME CBR3 |
[5] |
| Pharmaceutical Agent(s) |
| Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 5 Xenobiotics
|
| Acetaminophen |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Acetaminophen up-regulates the expression of DME CBR3 |
[6] |
| Bortezomib |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00159
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Bortezomib up-regulates the expression of DME CBR3 |
[7] |
| Copper sulfate |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Copper sulfate up-regulates the expression of DME CBR3 |
[8] |
| Cyclosporine |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Cyclosporine up-regulates the expression of DME CBR3 |
[9], [10] |
| Valproic acid |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Drug Approved by US FDA |
| DME Modulation |
Valproic acid up-regulates the expression of DME CBR3 |
[11] |
| Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Sulforafan |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO01478
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 3 |
| DME Modulation |
Sulforafan up-regulates the expression of DME CBR3 |
[12] |
| Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| MS-275 |
Click to Show/Hide the Detail |
Induction |
| XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Highest Clinical Status: Phase 2 |
| DME Modulation |
MS-275 up-regulates the expression of DME CBR3 |
[13] |
| Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
| Thioxotriazole copper(II) |
Click to Show/Hide the Detail |
Inhibition |
| XEOTIC ID |
XEO01081
XEOTIC Info
|
Gene Form |
mRNA |
| Classification |
Investigative Agent |
| DME Modulation |
Thioxotriazole copper(II) inhibits the expression of DME CBR3 |
[14] |
|
|
|
|
|
|